Does CENEGERMIN-BKBJ Cause Persistent corneal epithelial defect? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Persistent corneal epithelial defect have been filed in association with CENEGERMIN-BKBJ. This represents 0.1% of all adverse event reports for CENEGERMIN-BKBJ.
14
Reports of Persistent corneal epithelial defect with CENEGERMIN-BKBJ
0.1%
of all CENEGERMIN-BKBJ reports
0
Deaths
0
Hospitalizations
How Dangerous Is Persistent corneal epithelial defect From CENEGERMIN-BKBJ?
Of the 14 reports.
Is Persistent corneal epithelial defect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CENEGERMIN-BKBJ. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does CENEGERMIN-BKBJ Cause?
Eye pain (5,847)
Eye irritation (1,871)
Product dose omission issue (1,335)
Ocular hyperaemia (1,226)
Photophobia (1,065)
Vision blurred (944)
Wrong technique in product usage process (899)
Eye swelling (847)
Ocular discomfort (797)
Lacrimation increased (737)
What Other Drugs Cause Persistent corneal epithelial defect?
Which CENEGERMIN-BKBJ Alternatives Have Lower Persistent corneal epithelial defect Risk?
CENEGERMIN-BKBJ vs CENOBAMATE
CENEGERMIN-BKBJ vs CEPHALEXIN
CENEGERMIN-BKBJ vs CERITINIB
CENEGERMIN-BKBJ vs CERLIPONASE ALFA
CENEGERMIN-BKBJ vs CERTICAN